A high-throughput small-molecule ligand screen targeted to agonists and antagonists of the g-protein-coupled receptor GPR54

Journal of Biomolecular Screening

Volumn 15, Issue 5, 2010, Pages 508-517

  Kuohung, Wendy ^a,b   Burnett, Maria ^b   Mukhtyar, Deepa ^b   Schuman, Eli ^b   Ni, Jake ^b   Crowley, William F ^c   Glicksman, Marcie A ^b   Kaiser, Ursula B ^b  

^a BOSTON UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Agonist; Antagonist; GPR54; High throughput screening; Kisspeptin

Indexed keywords

G PROTEIN COUPLED RECEPTOR 54; G PROTEIN COUPLED RECEPTOR 54 AGONIST; G PROTEIN COUPLED RECEPTOR 54 ANTAGONIST; HORMONES AND AGENTS ACTING ON THE ENDOCRINE SYSTEM; INOSITOL PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; FLUORESCENCE ANALYSIS; HIGH THROUGHPUT SCREENING; NONHUMAN; OVARY CELL; PRIORITY JOURNAL; SCREENING; SIGNAL TRANSDUCTION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INOSITOL PHOSPHATES; LIGANDS; RECEPTORS, G-PROTEIN-COUPLED;

CRICETULUS GRISEUS;

EID: 77953628071     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057110369701     Document Type: Article

References (30)

1. Seminara SB, Messager S., Chatzidaki EE, Thresher RR, Acierno JS Jr, Shagoury JK,, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003 ; 349: 1614-1627.
2. de Roux N., Genin E., Carel JC, Matsuda F., Chaussain JL, Milgrom E.: Hypogonadotropic hypogonadism due to loss of function of the KiSS1derived peptide receptor GPR54. Proc Natl Acad Sci USA 2003 ; 100: 10972-10976.
3. Funes S., Hedrick JA, Vassileva G., Markowitz L., Abbondanzo S., Golovko A.,, et al. The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. Biochem Biophys Res Commun 2003 ; 312: 1357-1363.
4. Gottsch ML, Cunningham MJ, Smith JT, Popa SM, Acohido BV, Crowley WF,, et al. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 2004 ; 145: 4073-4077.
5. Dhillo WS, Chaudhri OB, Patterson M., Thompson EL, Murphy KG, Badman MK,, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary-gonadal axis in human males. J Clin Endocrinol Metab 2005 ; 90: 6613.
6. Matsui H., Takatsu Y., Kumano S., Matsumoto H., Ohtaki T.: Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat. Biochem Biophys Res Commun 2004 ; 320: 383-388.
7. Navarro VM, Castellano JM, Fernandez-Fernandez R., Barreiro ML, Roa J., Sanchez-Criado JE,, et al. Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide. Endocrinology 2004 ; 145: 4565-4574.
8. Navarro VM, Castellano JM, Fernandez-Fernandez R., Tovar S., Roa J., Mayen A.,, et al. Characterization of the potent LH releasing activity of KiSS-1 peptide, the natural ligand of GPR54. Endocrinology 2004 ; 146: 156-163.
9. Shahab M., Mastronardi C., Seminara SB, Crowley WF, Ojeda SR, Plant TM: Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci USA 2005 ; 102: 2129-2134.
10. Popa SM, Clifton DK, Steiner RA: The role of kisspeptins and GPR54 in the neuroendocrine regulation of reproduction. Annu Rev Physiol 2008 ; 70: 213-238.
11. Han SK, Gottsch ML, Lee KJ, Popa SM, Smith JT, Jakawich SK,, et al. Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty. J Neurosci 2005 ; 25: 11349-11356.
12. Franceschini I., Lornet D., Cateau M., Delsol G., Tillet Y., Caraty A.: Kisspeptin immunoreactive cells of the ovine preoptic area and arcuate nucleus co-express estrogen receptor alpha. Neurosci Lett 2006 ; 401: 225-230.
13. Smith JT, Cunningham MJ, Rissman EF, Clifton DK, Steiner RA: Regulation of Kiss1 gene expression in the brain of the female mouse. Endocrinology 2005 ; 146: 3686-3692.
14. Smith JT, Popa SM, Clifton DK, Hoffman GE, Steiner RA: Kiss1 neurons in the forebrain as central processors for generating the preovulatory luteinizing hormone surge. J Neurosci 2006 ; 26: 6687-6694.
15. Smith JT, Dungan HM, Stoll EA, Gottsch ML, Braun RE, Eacker SM,, et al. Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse. Endocrinology 2005 ; 146: 2976-2984.
16. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE,, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 1996 ; 88: 1731-1737.
17. Lee JH, Welch DR: Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. Int J Cancer 1997 ; 71: 1035-1044.
18. Hori A., Honda S., Asada M., Ohtaki T., Oda K., Watanabe T.,, et al. Metastin suppresses the motility and growth of CHO cells transfected with its receptor. Biochem Biophys Res Commun 2001 ; 286: 958-963.
19. Becker JA, Mirjolet JF, Bernard J., Burgeon E., Simons MJ, Vassart G.,, et al. Activation of GPR54 promotes cell cycle arrest and apoptosis of human tumor cells through a specific transcriptional program not shared by other Gq-coupled receptors. Biochem Biophys Res Commun 2005 ; 326: 677-686.
20. Navenot JM, Wang Z., Chopin M., Fujii N., Peiper SC: Kisspeptin-10- induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins. Cancer Res 2005 ; 65: 10450-10456.
21. Bedecarrats GY, Lindher KD, Kaiser UB: Two common naturally occurring mutations in the human gonadotropin-releasing hormone (GnRH) receptor have differential effects on gonadotropin gene expression and on GnRHmediated signal transduction. J Clin Endocrinol Metab 2003 ; 88: 834-843.
22. Lipinski CA, Lombardo F., Dominy BW, Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev 2001 ; 46 (1-3). 3-26.
23. Ohtaki T., Shintani Y., Honda S., Matsumoto H., Hori A., Kanehashi K.,, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001 ; 411: 613-617.
24. Zhang JH, Chung TDY, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999 ; 4 (2). 67-73.
25. Cassutt KJ, Orsini MJ, Abousleiman M., Colone D., Tang W.: Identifying nonselective hits from a homogeneous calcium assay screen. J Biomol Screen 2007 ; 12: 285-287.
26. Seminara SB, DiPietro MJ, Ramaswamy S., Crowley WF Jr, Plant TM: Continuous human metastin 45-54 infusion desensitizes GPR54-induced GnRH release monitored indirectly in the juvenile male rhesus monkey (Macaca mulatta): a finding with therapeutic implications. Endocrinology 2006 ; 147: 2122-2126.
27. Roseweir AK, Kauffman AS, Smith JT, Guerriero KA, Morgan K., Pielecka-Fortuna J.,, et al. Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J Neurosci 2009 ; 29: 3920-3929.
28. Niida A., Wang Z., Tomita K., Oishi S., Tamamura H., Otaka A.,, et al. Design and synthesis of downsized metastin (45-54) analogs with maintenance of high GPR54 agonistic activity. Bioorg Med Chem Lett 2006 ; 16: 134-137.
29. Orsini MJ, Klein MA, Beavers MP, Connolly PJ, Middleton SA, Mayo KH: Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening. J Med Chem 2007 ; 50: 462-471.
30. Gutierrez-Pascual E., Leprince J., Martinez-Fuentes AJ, Segalas-Milazzo I., Pineda R., Roa J.,, et al. In vivo and in vitro structure-activity relationships and structural conformation of kisspeptin-10-related peptides. Mol Pharmacol 2009 ; 76: 58-67.